tiprankstipranks
Denali Therapeutics (DNLI)
NASDAQ:DNLI

Denali Therapeutics (DNLI) Similar Stocks

Compare
666 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Denali Therapeutics
$15.95
$2.40B
-22.00%
16 Buy
0 Hold
0 Sell
Strong Buy
ACADIA Pharmaceuticals
$18.26
$3.05B
13.43
-23.12%
9 Buy
6 Hold
0 Sell
Moderate Buy
Biogen
$142.65
$20.57B
12.67
-34.33%
12 Buy
13 Hold
0 Sell
Moderate Buy
Neurocrine
$113.11
$11.41B
34.37
-15.38%
18 Buy
5 Hold
0 Sell
Strong Buy
Vertex Pharmaceuticals
$486.22
$123.21B
17.04%
15 Buy
11 Hold
1 Sell
Moderate Buy
PTC Therapeutics
$51.80
$4.36B
67.20%
6 Buy
3 Hold
2 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
DNLI
Denali Therapeutics
15.95
-4.50
-22.00%
ACAD
ACADIA Pharmaceuticals
18.26
-5.55
-23.31%
BIIB
Biogen
142.65
-74.58
-34.33%
NBIX
Neurocrine
113.11
-20.56
-15.38%
VRTX
Vertex Pharmaceuticals
486.22
70.78
17.04%
PTCT
PTC Therapeutics
51.80
20.50
65.50%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis